Lillie Shockney, R.N., B.S., M.A.S. – Director of Johns Hopkins Cancer Survivorship Programs
Associate professor of surgery, gynecology and oncology, Johns Hopkins University School of Medicine, and University Distinguished Service Associate Professor of Breast CancerMrs. Shockney is the Administrative Director of the Johns Hopkins Breast Center and also the Administrative Director of the Johns Hopkins Cancer Survivorship programs. She is a 20+ year breast cancer survivor, extensively published in the field of breast cancer survivorship, navigation, patient advocacy, and general cancer survivorship.
MySha Allen, RN – Oncology Nurse, Johns Hopkins Kimmel Cancer Center
Yukako Ichimiya – MPH Candidate, Johns Hopkins School of Public Health. Dr. Ichimiya, who served as a radiation oncologist in Japan, has a lifetime goal of working to reduce the burden of cancer on society.
Louise Knight, MSW, LCSW-C, OSW-C – Director of Patient and Family Services
Ms. Knight, a social worker with more than 20 years’ experience in cancer care, is the director of the Harry J. Duffey Family Patient and Family Services Program at the Johns Hopkins Kimmel Cancer Center. She guides a team of social workers who help navigate cancer patients through every realm of their care. Knight has lectured on how caregivers (family, friends, health care providers and colleagues) have taken on a new title: co-survivors, who lend cancer patients support from diagnosis through treatment and beyond.
Sharon Krumm, Ph.D., RN – Director of Nursing Administration, Johns Hopkins Kimmel Cancer Center
Dr. Krumm is the administrator and director of Nursing at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital and an associate professor at the Johns Hopkins School of Nursing and School of Medicine.
Terry Langbaum, MHS -- Chief Administrative Officer, Johns Hopkins Kimmel Cancer Center
Since 2001, Ms. Langbaum has served as the chief administrative officer of the Sidney Kimmel Comprehensive Cancer Center. In this service line role, she is charged with planning and managing cancer programming across departmental lines and institutional entities, including five hospitals and several ambulatory sites. She works with Mrs. Shockney on survivorship programming. She also is helping develop a “Cancer and the Workplace” program, as well as other programming for survivors.
Donald List, LCSW-C – Clinical Social Worker, Johns Hopkins Kimmel Cancer Center
Mr. List is a senior clinical social worker at Johns Hopkins. He works with the Harry J. Duffey Family Pain and Palliative Care Program.
Katherine Clegg Smith, Ph.D., – Associate Professor, Johns Hopkins Bloomberg School of Public Health
Dr. Smith is a sociologist with research interests around the social determinants of health behavior. She is currently leading a study funded by the National Cancer Institute and the NIH Office of Behavioral and Social Sciences Research to explore identity issues and dietary behaviors among long-term cancer survivors.
Breast Cancer Survivorship
Elissa Bantug, M.H.S. – Program Coordinator, Breast Cancer Survivorship Program
Ms. Bantug, a two-time breast cancer survivor by the age of 25, is an outspoken advocate for women living with breast cancer and has first-hand experience with some of the many concerns breast cancer can create, such as coping with long-term side effects, fertility, negotiating with employers while in treatment, survivorship care planning, navigating between medical professionals, and obtaining insurance. She has appeared in local and national television interviews, newspaper articles, magazine publications, and radio discussions speaking out about the unique barriers and challenges women with breast cancer face. Ms. Bantug holds an undergraduate degree from Georgetown University in Women's Health and a graduate degree from Johns Hopkins Bloomberg School of Public Health in Health Promotion and Health Education with a concentration in Women's Health Issues. She currently works as project coordinator of the Breast Cancer Survivorship Program at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Elisabeth Carrino-Tamasi, M.S.W., L.G.S.W., – Clinical Social Worker, the Johns Hopkins Kimmel Cancer Center
Ms. Carrino-Tamasi advises the breast center survivorship program on strategies and interventions needed to facilitate the transition of breast cancer patients from short-term to long-term survivorship care.
Melinda Kantsiper, M.D.– Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Kantsiper is a general internist with an interest in the transition of cancer patients from specialty to primary care, and in improved survivorship experiences for minority and uninsured populations.
Kimberly Peairs, M.D. – Assistant Professor of Medicine and Oncology, Johns Hopkins University School of Medicine
Dr. Peairs maintains a clinical practice with a focus on women’s health issues. She leads efforts to identify existing gaps of knowledge and educational resources for non-cancer physicians related to breast cancer survivorship and create a curriculum for use at Johns Hopkins and elsewhere.
Jennifer Barsky Reese, Ph.D. – Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Center
Dr. Reese’s research interests include developing, implementing and evaluating interventions to improve sexual and relationship health and quality of life for cancer survivors. She offers consultation and therapy to individuals and couples adjusting to life with and after cancer, specializing in addressing intimacy and sexual concerns.
Claire Snyder, Ph.D. -- Associate Professor of Medicine with joint appointments in Oncology and Health Policy & ManagementDr. Snyder’s research focuses on quality of cancer care in two areas: (1) quality of life for cancer patients undergoing treatment and (2) coordination of care for cancer survivors. She has conducted, presented and published studies examining the quality of survivorship care among colorectal and breast cancer survivors.
Antonio Wolff, M.D. -- Professor of Oncology, Johns Hopkins Avon Breast Center
Dr. Wolff’s research interests include new therapies, predictive biomarkers, cancer survivorship, and quality of care. His clinical practice at Johns Hopkins is dedicated exclusively to the care of patients diagnosed with breast cancer.
Colorectal Cancer Survivorship
Danielle Bischof, M.D. – Fellow, Johns Hopkins School of Medicine
Dr. Bischof’s clinical interest is in the area of surgical management of gastrointestinal cancers. Her research interests lie in cancer survivorship, specifically in improving patient-centered outcomes after surgical treatment of gastrointestinal cancers.
Michael Choti, M.D., MBA – Professor of Surgery; Oncology; and Radiology and Radiological Science, Johns Hopkins Medicine
Dr. Choti is the Jacob C. Handelsman Professor of Surgery and Oncology and vice chair of the Department of Surgery at Johns Hopkins School of Medicine. He is the principal or co-investigator for a variety of clinical and preclinical studies examining new approaches for the treatment of liver, pancreatic, and colorectal cancer. One focus of his research involves the use of robotics and computer assistance to surgically treat cancer using minimally invasive image-guided approaches. This work has been funded through a series of NIH grants and industry collaborations. He also has a strong interest in molecular genetics and biomarkers in gastrointestinal cancer, as well as clinical research, conducting clinical trials and outcomes research in hepatobiliary, pancreatic, and gastrointestinal malignancies.
Luis A. Diaz, M.D.– Associate Professor of Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Diaz directs the colorectal survivorship clinic and the Swim Across America research laboratory at Johns Hopkins Kimmel Cancer Center. His research interests involve combining world-class basic science research with clinical knowledge to produce novel diagnostic, predictive and therapeutic agents for cancer patients. Dr. Diaz’ area of concentration in the laboratory has been in the preclinical development of COBALT (Combination Bacteriolytic Therapy), and development of a protocol for testing it.
Maura Kadan, RN, MSN, OCN – Clinical Program Manager, Colorectal Cancer Service, Johns Hopkins Hospital
Ms. Kadan works with the colorectal cancer survivorship clinic.
Eden Stotsky-Himelfarb, RN, BSN -- Health Education/Program Coordinator, the Johns Hopkins Colon Cancer Center
Mrs. Stotsky-Himelfarb, a colorectal cancer survivor, is a nurse clinician for the gastrointestinal surgical oncology group at the Johns Hopkins Kimmel Cancer Center. She coordinates a buddy network for colorectal cancer patients, matching survivor volunteers with newly diagnosed patients.
Gynecologic Cancer Survivorship
Nancy Farruggia, RN, BSN – Ambulatory Care Coordinator, Kelly Gynecologic Oncology Service
Ms. Farruggia works with patients with ovarian, fallopian tube, endometrial, cervical and vulvar cancer, triaging patient phone calls, answering questions/addressing concerns before and after surgery, and following chemotherapy.
Sharon D. Thompson, BSN, OCN -- Chemotherapy Nurse Coordinator, Kelly Gynecologic Oncology Service
Ms. Thompson is responsible for ongoing support and care of gynecologic oncology patients, focusing on assessment, counseling, education, coordination of care, treatment procedures, and unexpected complications associated with chemotherapy. She has special interest and expertise in the area of intraperitoneal chemotherapy for ovarian cancer patients.
Head and Neck Cancer Survivorship
Amy Brady – Program Coordinator, Head and Neck Cancer Multidisciplinary Program
Christine Gourin, M.D., MPH – Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medicine
Dr. Gourin is director of the Clinical Research Program in Head and Neck Cancer. Her research interests include quality of life, functional outcomes, and survival following treatment for head and neck cancer.
Harry Quon, M.D. – Associate Professor of Radiation Oncology and Molecular Radiation Sciences; Oncology; and Otolaryngology-head and Neck Surgery, Johns Hopkins Medicine
Dr. Quon is director of head and neck radiation oncology at Johns Hopkins. He has extensive experience with the delivery of radiation therapy after transoral robotic surgery. He also is leading research into different strategies that are de-intensifying therapy in oropharynx cancers associated with the human papillomavirus (HPV).
Jeremy Richmon, M.D.– Assistant Professor of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medicine
Dr. Richmon is the director of the head and neck surgery robotic program at Johns Hopkins Hospital. He is using the surgical robot to assist with removing tumors from the throat and larynx through the mouth as well as performing robotic thyroidectomy. Dr. Richmon has been working closely with the Whiting School of Engineering at Johns Hopkins University to push the boundaries of current robotic technology specifically for applications within the head and neck. His clinical interests include head and neck cancer, skull base surgery, robotic surgery, and microvascular reconstruction of the head and neck.
Heather Starmer, MA, CCC-SLP – speech language pathologist, Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins Medicine
Ms. Starmer is an assistant professor in the Department of Otolaryngology--Head and Neck Surgery at Johns Hopkins. Her areas of clinical and research interest include management of speech and swallowing deficits associated with head and neck cancer, laryngectomy rehabilitation, and voice disorders. She has a particular interest in issues of survivorship care during and following treatment for head and neck cancers.
Robert Arceci, M.D., Ph.D. – Professor of Oncology and Pediatrics; King Fahd Professor of Pediatric Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Arceci, a co-director of the Michael J. Garil Leukemia Survivors Program, is considered an international authority in many challenging areas of clinical pediatric oncology including the diagnosis and treatment of leukemia and histiocytic disorders. His research interests include targeted therapies for leukemia, predisposition to leukemias, and leukemia late effects.
Judith Karp, M.D.– Professor of Medicine and Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Karp is director of the Leukemia Program. Her research interests focus on the experimental therapeutics of acute leukemias, including development of timed sequential therapy, new biologic agents for older adults with acute leukemias, and new approaches to the treatment of refractory acute leukemias including secondary leukemias that evolve from myelodysplasia or from prior cytotoxic chemotherapies.
Kathy Ruble, Ph.D., R.N.– Co-Director, Michael J. Garil Leukemia Survivorship Program
Dr. Ruble helped develop the Leukemia Survivorship Program at Johns Hopkins. She and her colleagues monitor child and adolescent leukemia survivors and educate them on possible long-term effects of cancer and therapy. Her research interests include analyzing and minimizing cardiovascular risk factors for long-term survivors.
B. Douglas Smith, M.D. – Associate Professor of Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Smith’s research focuses on taking new, promising laboratory insights and developing them into biology-based treatment approaches for patients with acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and myelodysplastic syndrome (MDS). His work has helped to translate numerous novel therapies into the clinic, including differentiation-based strategies, small molecule inhibitors of signal transduction pathways (FLT3-ITD, raf kinase, ras kinase, and bcr-abl), and immunomodulatory approaches. Dr. Smith is a recognized national leader in new therapeutics for AML and CML and currently serves on the National Comprehensive Cancer Network guideline panels for both diseases.
Lung Cancer Survivorship
Peggy Lang, MSN, CRNP – Thoracic Oncology Coordinator
Ms. Lang leads education classes for the Thoracic Oncology Multidisciplinary Clinic, teaching patients and their caregivers about lung cancer, different treatments, how to stay healthy during treatment, opportunities to participate in clinical trials and how to access services at Johns Hopkins.
Evan Lipson, M.D. – Instructor of Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Lipson, a melanoma specialist, focuses on investigating new therapies for patients with various stages of melanoma, ranging from preventing disease recurrence in high-risk patients to developing innovative drug therapies for patients with advanced disease. Dr. Lipson is also the founder of Seize the Days, Inc., a non-profit organization that chronicles the stories of cancer patients who, with power and determination, find interesting and meaningful ways to add life to their days. Those stories are available online at seizethedays.org.
Kim Palmer – Melanoma Coordinator, Johns Hopkins Kimmel Cancer Center
Prostate Cancer Survivorship
Michael Carducci, M.D. – Professor of Oncology and Urology, Johns Hopkins Kimmel Cancer Center
Dr. Carducci co-leads the Prostate Cancer / Genitourinary Oncology Program and the Chemical Therapeutics Program. A translational researcher, Dr. Carducci directs a laboratory program focused on the re-expression of epigenetically silenced genes in cancer cells via the use of small molecules, and manages a portfolio of clinical trials targeted at introducing these small molecules into cancer treatment. His research focus is on the development and evaluation of new therapies for genitourinary cancers, specifically prostate and renal cancers. Areas of particular interest are bone-targeted therapies, epigenetic strategies, as well as general early phase drug development leading to first-in-human clinical trials.
Channing Paller, M.D. – Assistant Professor of Oncology, Johns Hopkins Kimmel Cancer Center
Dr. Paller’s focus is on clinical trials of developmental therapeutics in prostate and other solid tumors. She was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology (ASCO) and for the 2011-12 Paul Carbone Award by the Eastern Cooperative Oncology Group.
Craig Pollack, M.D., MHS – Assistant Professor of Medicine, Johns Hopkins School of Medicine, with a joint appointment in the Bloomberg School of Public Health and membership in the Johns Hopkins Kimmel Cancer Center
Dr. Pollack practices as a primary care physician. His research focuses on cancer prevention and control with an emphasis on prostate cancer. His work seeks to understand how the organization environment of health care influences the type and quality of care that patients receive. In other work, he examines the broader social context of health and health care, particularly on housing, financial strain and socioeconomic status.
Victoria Sinibaldi, CRNP – Research Associate, Program Coordinator, Johns Hopkins Kimmel Cancer Center
Young Adults with Cancer
Alexandra Gubin, MSW, LGSW – Clinical Social Worker and Young Adult Patient Navigator, Johns Hopkins Kimmel Cancer Center
Ms. Gubin works in conjunction with the Ulman Cancer Fund for Young Adults and a multidisciplinary team of healthcare professionals at the Kimmel Center to improve the cancer experience for young adults and to address the unique needs and of young adult patients and their families. She works with adolescents and young adults ages 15 to 39, in treatment and post-treatment, providing resources and supportive counseling designed to empower young adult patients and their families to take an active role in their cancer experience and supporting them as they face the challenges of a cancer diagnosis.
R. Samuel Mayer, M.D., – Vice Chair, Department of Physical Medicine and Rehabilitation, The Johns Hopkins Hospital
Dr. Mayer’s interests include cancer rehabilitation, and complications of critical illness, spine disorders, pain management, and disorders of muscle tone.
Michael Friedman, PT, MBA – Director, Physical Medicine and Rehabilitation Therapy Services, The Johns Hopkins Hospital
Laurie Sweet, PT – Manager, Outpatient Services, Physical Medicine and Rehabilitation Therapy Services, The Johns Hopkins Hospital